drugset / Trial / NCT07187765

Respiratory Safety of Oliceridine During Sedated Gastrointestinal Endoscopy

NCT07187765

Completed 508 enrolled Shiyou Wei
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a prospective, single-center, double-blind, randomized controlled trial designed to evaluate the effect of oliceridine versus sufentanil on the incidence of hypoxemia in adult patients undergoing gastrointestinal endoscopy under deep sedation. The trial will compare the rates of hypoxemia (defined as SpO₂ ≤92%) between the two analgesic regimens when combined with propofol. The primary aim is to determine whether oliceridine can reduce the incidence of hypoxemia compared to sufentanil during endoscopic procedures.

Timeline

Start
2025-09-22
Primary completion
2025-11-30
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oliceridine Other / unclassified 1 mg Intravenous
Subject Oliceridine Other / unclassified 1.5 mg Intravenous
Comparator Sufentanil Other / unclassified 5 ug Intravenous
Comparator Sufentanil Other / unclassified 7.5 ug Intravenous

Indications

No indication recorded.